These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30715413)

  • 1. Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
    Crank MC; Mascola JR; Graham BS
    J Infect Dis; 2019 Apr; 219(Suppl_1):S107-S109. PubMed ID: 30715413
    [No Abstract]   [Full Text] [Related]  

  • 2. How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.
    Rudraraju R; Mordant F; Subbarao K
    J Infect Dis; 2019 Apr; 219(Suppl_1):S81-S87. PubMed ID: 30715386
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection.
    Eichelberger MC; Monto AS
    J Infect Dis; 2019 Apr; 219(Suppl_1):S75-S80. PubMed ID: 30715357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza Vaccines: Good, but We Can Do Better.
    Paules CI; Fauci AS
    J Infect Dis; 2019 Apr; 219(Suppl_1):S1-S4. PubMed ID: 30715469
    [No Abstract]   [Full Text] [Related]  

  • 5. Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic.
    Morens DM; Taubenberger JK
    J Infect Dis; 2019 Apr; 219(Suppl_1):S5-S13. PubMed ID: 30715352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of live attenuated influenza vaccines against pandemic influenza strains.
    Coelingh KL; Luke CJ; Jin H; Talaat KR
    Expert Rev Vaccines; 2014 Jul; 13(7):855-71. PubMed ID: 24867587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2015 Oct; 90(42):561-71. PubMed ID: 26477059
    [No Abstract]   [Full Text] [Related]  

  • 8. Universal Influenza Vaccine Approaches Using Full-Length or Head-Only Hemagglutinin Proteins.
    Ross TM
    J Infect Dis; 2019 Apr; 219(Suppl_1):S57-S61. PubMed ID: 30715379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Oct; 87(42):401-12. PubMed ID: 23113329
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Mar; 87(11):97-108. PubMed ID: 22462204
    [No Abstract]   [Full Text] [Related]  

  • 11. Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.
    Morgan SB; Hemmink JD; Porter E; Harley R; Shelton H; Aramouni M; Everett HE; Brookes SM; Bailey M; Townsend AM; Charleston B; Tchilian E
    J Immunol; 2016 Jun; 196(12):5014-23. PubMed ID: 27183611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope specific T-cell responses against influenza A in a healthy population.
    Savic M; Dembinski JL; Kim Y; Tunheim G; Cox RJ; Oftung F; Peters B; Mjaaland S
    Immunology; 2016 Feb; 147(2):165-77. PubMed ID: 26489873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2013 Oct; 88(42):449-63. PubMed ID: 24159668
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2014 Mar; 89(11):105-15. PubMed ID: 24707515
    [No Abstract]   [Full Text] [Related]  

  • 15. The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines.
    Saelens X
    J Infect Dis; 2019 Apr; 219(Suppl_1):S68-S74. PubMed ID: 30715367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2013 Mar; 88(11):117-25. PubMed ID: 23544238
    [No Abstract]   [Full Text] [Related]  

  • 17. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2017 Mar; 92(12):129-44. PubMed ID: 28337863
    [No Abstract]   [Full Text] [Related]  

  • 18. Universal influenza vaccines: a realistic option?
    de Vries RD; Altenburg AF; Rimmelzwaan GF
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S120-S124. PubMed ID: 27130671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Learning from the 2009 H1N1 pandemic: prospects for more broadly effective influenza vaccines.
    Settembre EC; Dormitzer PR; Rappuoli R
    J Mol Cell Biol; 2011 Jun; 3(3):144-6. PubMed ID: 21430014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccine--outmaneuvering antigenic shift and drift.
    Treanor J
    N Engl J Med; 2004 Jan; 350(3):218-20. PubMed ID: 14724300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.